buserelin has been researched along with Cancer of Pancreas in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beger, HG; Büchler, M; Friess, H; Krüger, M | 1 |
| Bonadimani, B; Cappellazzo, F; Catalini, S; Militello, C; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Bakker, GH; de Jong, FH; Foekens, JA; Klijn, JG; Meijers, M; van Garderen-Hoetmer, A; Woutersen, RA | 1 |
| Andrén-Sandberg, A | 1 |
1 trial(s) available for buserelin and Cancer of Pancreas
| Article | Year |
|---|---|
Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin).
Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Buserelin; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Goserelin; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Survival Analysis | 1992 |
3 other study(ies) available for buserelin and Cancer of Pancreas
| Article | Year |
|---|---|
Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin.
Topics: Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Buserelin; Carcinoembryonic Antigen; Estradiol; Female; Humans; Male; Middle Aged; Pancreatic Ducts; Pancreatic Neoplasms; Survival Rate; Testosterone | 1992 |
Effects of castration, alone and in combination with aminoglutethimide, on growth of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters.
Topics: Aminoglutethimide; Animals; Azaserine; Body Weight; Buserelin; Carcinogens; Cricetinae; Epidermal Growth Factor; Gastrins; Goserelin; Male; Mesocricetus; Nitrosamines; Orchiectomy; Organ Size; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Strains; Somatomedins; Testosterone | 1991 |
Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Buserelin; Drug Implants; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies | 1990 |